SCHEMBL1679378

SCHEMBL1679378

CC(O)c1cc(C(C)C(=O)O)ccc1-c1ccc(O)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.66
APP P05067 3/20 0.66
CYP2C9 P11712 2/20 0.66
CYP3A4 P08684 1/20 0.66
AKR1C3 P42330 12/20 0.51
AKR1C2 P52895 12/20 0.51
PTGS2 P35354 4/20 0.51
PTGS1 P23219 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
PSEN1 P49768 2/20 0.51
PSEN2 P49810 2/20 0.51
APH1B Q8WW43 2/20 0.51
NCSTN Q92542 2/20 0.51
APH1A Q96BI3 2/20 0.51
PSENEN Q9NZ42 2/20 0.51
FABP2 P12104 1/20 0.51
TSHR P16473 1/20 0.51
AKR1C4 P17516 1/20 0.51
ADRA2B P18089 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1679126 0.90 CYP2C19 (0.68) CYP2C19APPCYP2C9CYP3A4AKR1C3
SCHEMBL1679163 0.81 APP (0.68) CYP2C19APPCYP2C9CYP3A4AKR1C3
4'-Hydroxyflurbiprofen SCHEMBL7040151 0.81 APP (0.97) CYP2C19APPCYP2C9CYP3A4AKR1C3
4'-Hydroxyflurbiprofen SCHEMBL6450842 0.81 APP (0.97) CYP2C19APPCYP2C9CYP3A4AKR1C3
SCHEMBL1679397 0.79 CYP2C19 (0.66) CYP2C19APPCYP2C9CYP3A4AKR1C3
SCHEMBL1679355 0.79 CYP2C19 (0.66) CYP2C19APPCYP2C9CYP3A4AKR1C3
SCHEMBL2778899 0.79 APP (1.00) CYP2C19APPCYP2C9CYP3A4AKR1C3
SCHEMBL1679245 0.79 CYP2C19 (0.61) CYP2C19APPCYP2C9CYP3A4AKR1C3
SCHEMBL1679393 0.78 CYP2C19 (0.64) CYP2C19APPCYP2C9CYP3A4AKR1C3
SCHEMBL1678786 0.77 PTGS2 (0.74) CYP2C19APPCYP2C9CYP3A4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923573-B2 Benzene compound having 2 or more substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-04-12 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004301-A1 Benzene Compound Having 2 or More Substituents NR1H2, NR1H3, NCOR2 CYP2C19 238/4885APP 1870/4885CYP2C9 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.